Patents
Literature
6 results about "Drusen" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Drusen, from the German word for node or geode (singular, "Druse"), are tiny yellow or white accumulations of extracellular material that build up between Bruch's membrane and the retinal pigment epithelium of the eye. The presence of a few small ("hard") drusen is normal with advancing age, and most people over 40 have some hard drusen. However, the presence of larger and more numerous drusen in the macula is a common early sign of age-related macular degeneration (AMD).
Methods of treating age-related macular degeneration
Methods of treating age-related macular degeneration (AMD) may include the administration of amphipathic, ATP binding cassette transporter membrane agonists to reduce the amount of drusen in the subject in need thereof. These methods may be particularly useful for treatment of intermediate AMD.
Owner:CHARACTER BIOSCIENCES INC
Detecting and tracking macular degeneration
A system includes a vision screening device having at least one sensor. The system also includes a controller operably connected to the at least one sensor. The controller is configured to cause the at least one sensor to obtain an image of an eye, and to identify a region of interest associated with a macula of the eye. The controller is also configured to identify drusen disposed proximate the macula, and to generate an augmented image of the eye. The augmented image includes a component indicating the drusen.
Owner:WELCH ALLYN INC
Peptide compositions and methods for treating retinal diseases and disorders
PCT designated stageWO2026112194A1Peptide/protein ingredientsPharmaceutical delivery mechanismDiseaseDrusen
Owner:OSANNI BIO INC +2
Superoxide dismutase and uses thereof for preventing or treating macular degeneration
PendingUS20250381252A1Senses disorderPeptide/protein ingredientsSuperoxide dismutasesPharmacy medicine
The present invention relates to superoxide dismutase and a use thereof for preventing or treating dry age-related macular degeneration. More specifically, the present invention relates to a pharmaceutical composition or a therapeutic method for prevention or treatment of dry macular degeneration. The composition and method according to the present invention can be effectively used to prevent or treat dry macular degeneration by reducing or preventing drusen formation and / or drusenoid lesions.
Owner:BIOMLOGIC INC +1